Claim this
Startup
Write to the
ApoVax

About ApoVax

ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville. ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory mole...

ApoVax describes itself with 2 words or categories

Bio-PharmBiotechnology

Video

Presentation

Case Study

Competitive Landscape

Capitalization

ApoVax appears to have raised $375,000.

  • #DATA_YEAR# : $
    #NAME#
    from #DATA_FROM#